| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 10/23/2013 | CN102429825B Natural biomineralization powder, preparation method thereof and application thereof |
| 10/23/2013 | CN102379971B Compound propolis composition for treating cage layer fatigue and preparation method thereof |
| 10/23/2013 | CN102362973B Medicinal composition for treating calciprivia in children and preparation method thereof |
| 10/23/2013 | CN102089287B Tetrahydrocinnolines as 11 beta HSD1 inhibitors for diabetes |
| 10/23/2013 | CN102018743B Chinese medicinal capsules for treating diabetes and complicating diseases and preparation method thereof |
| 10/23/2013 | CN101906158B Pegylation hypoglycemic polypeptide and preparation method and application thereof |
| 10/23/2013 | CN101863755B Chromium malate complex and preparation method and application thereof |
| 10/23/2013 | CN101679298B Fused bicyclic heteroaryl derivatives |
| 10/23/2013 | CN101437493B DPP IV inhibitor formulations |
| 10/22/2013 | US8563581 Nitroxides for use in treating predisposed or at risk patients |
| 10/22/2013 | US8563538 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 10/22/2013 | US8563519 Methods of activating or inhibiting G protein coupled receptors (GPCRs) |
| 10/22/2013 | US8563042 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 10/22/2013 | US8563014 Modafinil oral lyophilizate |
| 10/22/2013 | US8563000 Melanocortin receptor ligands modified with hydantoin |
| 10/22/2013 | US8562975 Method for stabilizing reduced coenzyme Q10 and composition therefor |
| 10/22/2013 | US8562952 Methods for manipulating satiety |
| 10/22/2013 | CA2778381C Dietary supplement, and methods of use |
| 10/22/2013 | CA2620296C Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
| 10/22/2013 | CA2619287C 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 10/22/2013 | CA2412626C Il-17 molecules and uses thereof |
| 10/22/2013 | CA2359926C Antagonists of hmg1 for treating inflammatory conditions |
| 10/17/2013 | WO2013155512A2 Treatment of ischemic retinopathies |
| 10/17/2013 | WO2013155476A1 Composition and method for modulating inflammatory molecules with amylase |
| 10/17/2013 | WO2013154766A1 Microrna control of ldl receptor pathway |
| 10/17/2013 | WO2013154163A1 Novel 5-aryl-1,2-thiazinane derivative |
| 10/17/2013 | WO2013154128A1 Novel arteriosclerosis treatment drug composition and method for screening arteriosclerosis treatment drugs |
| 10/17/2013 | WO2013153821A1 Pdk4 inhibitor and use thereof |
| 10/17/2013 | WO2013152717A1 Fused pyrimidine compound, and preparation method, intermediate, composition， and uses thereof |
| 10/17/2013 | WO2013152704A1 5-amino-1,4-dihydro-1,8-naphthyridine derivative and pharmaceutical composition and use thereof |
| 10/17/2013 | WO2013152654A1 Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2) inhibitors |
| 10/17/2013 | US20130273182 A Herbal Extract for Treating Fatty Liver Disease and a Medication Thereof |
| 10/17/2013 | US20130273175 Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation |
| 10/17/2013 | US20130273042 Treatment of multiple sclerosis |
| 10/16/2013 | EP2650299A1 Crystalline salts of sitagliptin |
| 10/16/2013 | EP2650298A1 Crystalline salts of sitagliptin |
| 10/16/2013 | EP2650297A1 Crystalline salts of sitagliptin |
| 10/16/2013 | EP2650296A1 Crystalline salts of sitagliptin |
| 10/16/2013 | EP2650005A2 Composition comprising fermented tea extracts for reducing lipid level |
| 10/16/2013 | EP2650002A1 Bifidobacterium cect 7765 and use thereof in the prevention and/or treatment of excess weight, obesity and related pathologies |
| 10/16/2013 | EP2649070A1 Triazolopyridine compounds |
| 10/16/2013 | EP2648516A1 Substituted pyridinone-pyridinyl compounds |
| 10/16/2013 | CN103354757A Treatment for lipodystrophy |
| 10/16/2013 | CN103354745A Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof |
| 10/16/2013 | CN103351420A Compound obtained from Momordica charantia L. through separation and preparation method and application thereof |
| 10/16/2013 | CN103351407A Novel crystal form of cocarboxylase tetrahydrate |
| 10/16/2013 | CN103351391A Compound serving as dipeptidyl enzyme inhibitor, composite of compound, and applications of compound and composite |
| 10/16/2013 | CN103351389A Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
| 10/16/2013 | CN103351388A Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines |
| 10/16/2013 | CN103351336A Naphthalenecarboxamide derivative as inhibitors of protein kinase and histone deacetylase and preparation method thereof |
| 10/16/2013 | CN103351285A Diethylstilbestrol compound and application thereof in preparation of drug for treating osteoporosis and hyperlipemia |
| 10/16/2013 | CN103349784A Microsphere particle hydrogel medicine carrier for injection, and preparation method and application thereof |
| 10/16/2013 | CN103349779A Healthcare soft capsule containing elements, vitamins and vegetable polyketide synthase and used for controlling cardiovascular and cerebrovascular diseases |
| 10/16/2013 | CN103349775A Method for preparing hypoglycemic agent or hypoglycemic food with natural biological active proteins of rice |
| 10/16/2013 | CN103349774A Drug for treating diabetes mellitus |
| 10/16/2013 | CN103349762A Traditional Chinese medicine used for treating type II diabetes |
| 10/16/2013 | CN103349751A Mongolian medicine composition for treating diabetic nephropathy and preparation method thereof |
| 10/16/2013 | CN103349749A Traditional Chinese medicine prescription for treating hyperlipemia |
| 10/16/2013 | CN103349745A Traditional Chinese medicine decoction used for treating diabetes |
| 10/16/2013 | CN103349732A Dendrobium officinale kimura et migo-panax quinquefolius buccal tablets for diabetes patients, and preparation method thereof |
| 10/16/2013 | CN103349706A Traditional Chinese medicine processing method for prepared rehmannia root |
| 10/16/2013 | CN103349685A Traditional Chinese medicine comprising radix paeoniae rubra and preparation method thereof |
| 10/16/2013 | CN103349675A Medical use of vegetable soybeans in diabetes prevention and treatment |
| 10/16/2013 | CN103349671A Resveratrol and spirulina composition and preparations and preparation method thereof |
| 10/16/2013 | CN103349669A Malic acid-containing composite dialysis preparation and preparation method thereof |
| 10/16/2013 | CN103349666A Pharmaceutical composition injection of compound liposoluble vitamin and preparation method thereof |
| 10/16/2013 | CN103349665A High calcium syrup |
| 10/16/2013 | CN103349656A Valsartan capsule and preparation method thereof |
| 10/16/2013 | CN103349645A Stabilized micronised particles |
| 10/16/2013 | CN102934806B Mutton sausage |
| 10/16/2013 | CN102934803B Health-care crocodile sausage |
| 10/16/2013 | CN102784274B Medicine for treating and nursing diabetic feet |
| 10/16/2013 | CN102754824B Health food for relieving hyperlipemia |
| 10/16/2013 | CN102698135B Traditional Chinese medicine composition for treating hypertension, hyperglycemia and hyperlipidemia, and application thereof |
| 10/16/2013 | CN102670670B Preparation method of ginkgo dipyridolum injection with high content of ginkgo terpene lactones |
| 10/16/2013 | CN102526151B Medicinal composition and application thereof |
| 10/16/2013 | CN102488202B Medicinal composition for treating diabetes and preparation method thereof |
| 10/16/2013 | CN102432760B Quaternary amine konjac glucomannan adduct, its preparation method and application |
| 10/16/2013 | CN102416107B Medicament for treating cerebral vascular disease |
| 10/16/2013 | CN102372741B Zoledronic acid crystal and lyophilized powder injection thereof |
| 10/16/2013 | CN102302512B Multi-vitamin mineral tablet |
| 10/16/2013 | CN102215850B A composition comprising extraction of fucoxanthin |
| 10/16/2013 | CN102210866B Oral preparation for slowing down absorption of alpha-glycosidase inhibitor and enhancing hypoglycemic drug effect |
| 10/16/2013 | CN102138888B Alprostadil lipid nanosphere gel and preparation method thereof |
| 10/16/2013 | CN102083799B Benzimidazole derivatives used as FXR agonists |
| 10/16/2013 | CN101935301B Modulators of ATP-binding cassette transporters |
| 10/16/2013 | CN101873866B Therapeutic or prophylactic agent, detection method and detection agent for metabolic syndrome, and method for screening of candidate compound for therapeutic agent for metabolic syndrome |
| 10/16/2013 | CN101801400B Use of yeast flakes for treating and/or preventing hyperinsulinemia |
| 10/16/2013 | CN101784543B Indole and indazole compounds as an inhibitor of cellular necrosis |
| 10/16/2013 | CN101605905B Method for glycosylation of flavonoid |
| 10/16/2013 | CN101531657B Dimethyldiguanide of the thiazolidinedione pharmaceutical, preparation method and use thereof |
| 10/16/2013 | CN101506203B 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other syndromes |
| 10/15/2013 | US8558009 Pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 10/15/2013 | US8557967 Anti-interferon-α antibodies |
| 10/15/2013 | US8557841 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 10/15/2013 | US8557785 In vivo production of small interfering RNAS that mediate gene silencing |
| 10/15/2013 | US8557771 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof |
| 10/15/2013 | US8557767 Synthetic apolipoprotein E mimicking polypeptides and methods of use |
| 10/15/2013 | US8557765 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 10/15/2013 | US8557240 Method for the treatment of inflammatory disorders |